Permeability change and brain tissue damage after intracarotid administration of cisplatin studied by double-tracer autoradiography in rats

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Neuro-Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF01052839PMID 7595753
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Supraophthalmic carotid infusion for recurrent glioma: Rationale, technique, and preliminary results for cisplatin and BCNU

  2004cited by this paper
• Capillary permeability in experimental rat glioma and effects of intracarotid CDDP administration on tumor drug delivery

  1993influential reference
• Pharmacokinetic study of selective continuous internal carotid CDDP infusion in malignant brain tumors.

  1991cited by this paper
• Intra-arterial cisplatin for the treatment of malignant gliomas

  1989cited by this paper
• Intracarotid cisplatin chemotherapy for recurrent gliomas.

  1989cited by this paper
• Intravascular Streaming and Variable Delivery to Brain following Carotid Artery Infusions in the Sprague-Dawley Rat

  1988cited by this paper
• Reduced cerebral glucose metabolism and increased brain capillary permeability following high‐dose methotrexate chemotherapy: A positron emission tomographic study

  1987cited by this paper
• [13N]cisplatin PET to assess pharmacokinetics of intra-arterial versus intravenous chemotherapy for malignant brain tumors.

  1987cited by this paper
• Imaging Studies of Patients with Malignant Fibrous Histiocytoma Using C-11-Alpha-Aminoisobutyric Acid (AIB)

  1987cited by this paper
• Mixing studies during intracarotid artery infusions in an in vitro model.

  1986cited by this paper
• Pharmacokinetics of intra-arterial and intravenous cisplatin in head and neck cancer patients.

  1986cited by this paper
• Acute high‐dose methotrexate neurotoxicity in the rat

  1986cited by this paper
• Neurological deficit after carotid infusion of cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) for malignant glioma: an analysis of risk factors.

  1986cited by this paper
• Drug streaming during intra-arterial chemotherapy.

  1986cited by this paper
• Ultrafiltrate and total platinum in plasma and cerebrospinal fluid in a patient with neuroblastoma.

  1985cited by this paper
• Intra‐arterial and intravenous chemotherapy for the treatment of malignant glioma: Preliminary results

  1985cited by this paper
• Intracarotid infusion of cis‐diamminedichloroplatinum in the treatment of recurrent malignant brain tumors

  1984cited by this paper
• An Improved Approach for Measurement of Regional Cerebral Rate Constants in the Deoxyglucose Method with Positron Emission Tomography

  1984cited by this paper
• Evaluation of [18F]-4-Fluoroantipyrine as a New Blood Flow Tracer for Multiradionuclide Autoradiography

  1984cited by this paper
• Use of Short-Lived 18F and Long-Lived 14C in Double Tracer Autoradiography for Simultaneous Measurement of LCBF and LCGU

  1984cited by this paper
• Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin.

  1984cited by this paper
• Etoposide-induced blood-brain barrier disruption. Effect of drug compared with that of solvents.

  1984cited by this paper
• Transport of α-Aminoisobutyric Acid across Brain Capillary and Cellular Membranes

  1983cited by this paper
• Neurotoxicity of chemotherapeutic agents after blood‐brain barrier modification: Neuropathological studies

  1983influential reference
• Transport of alpha-aminoisobutyric acid across brain capillary and cellular membranes.

  1983cited by this paper
• Selection of Experimental Conditions for the Accurate Determination of Blood — Brain Transfer Constants from Single-Time Experiments: A Theoretical Analysis

  1983cited by this paper
• Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II).

  1983cited by this paper
• Intraarterial Cis-Platinum Chemotherapy for Patients with Primary and Metastatic Brain Tumors

  1983cited by this paper
• Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors.

  1982cited by this paper
• A phase I study of intracarotid artery infusion of cis-Diamminedichloroplatinum(II) in patients with recurrent malignant intracerebral tumors.

  1982cited by this paper
• Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals.

  1979cited by this paper
• Kinetics of cis‐dichlorodiammineplatinum

  1979cited by this paper
• Platinum nephrotoxicity.

  1978cited by this paper
• Measurement of local cerebral blood flow with iodo [14C] antipyrine.

  1978cited by this paper
• Insulin effects on monovalent cation transport and Na-K-ATPase activity.

  1978cited by this paper
• Theoretic limitations of intracarotid infusions in brain tumor chemotherapy.

  1977cited by this paper
• Pharmacodynamics and the blood-brain barrier.

  1977cited by this paper
• Pharmacodynamics and the blood-brain barrier.

  1977cited by this paper
• THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1

  1977cited by this paper
• Theoretic limitations of intracarotid infusions in brain tumor chemotherapy.

  1977cited by this paper
• The nephrotoxic effects of cis-diammine-dichloroplatinum (II) (NSC-119875) in male F344 rats.

  1976influential reference
• Synthesis and distribution of a radiolabeled antitumor agent: cis-diamminedichloroplatinum. II.

  1972cited by this paper
• Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat.

  1971cited by this paper
• Antileukaemic and Nephrotoxic Properties of Platinum Compounds

  1971cited by this paper
• Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat.

  1971cited by this paper
• SELECTIVE VULNERABILITY OF THE BLOOD‐BRAIN BARRIER IN CHEMICALLY INDUCED LESIONS

  1966cited by this paper

• The effects of doxorubicin on blood-brain barrier integrity in hCMEC/D3

  2025cites this paper
• Elucidating the mechanism of traditional Chinese medicine formula (Yifei-sanjie Pill) in alleviating the chemobrain based on network pharmacology and experimental verification

  2024cites this paper
• Chemotherapy-associated hemorrhagic posterior reversible encephalopathy syndrome (PRES) with considerations for circle of Willis variants on cerebral blood flow and autoregulation: A case report

  2024cites this paper
• Posterior Reversible Encephalopathy Syndrome Secondary to R-CHOP Chemotherapy Regimen

  2022cites this paper
• Chemotherapy-Induced Cognitive Impairment and Hippocampal Neurogenesis: A Review of Physiological Mechanisms and Interventions

  2021cites this paper
• Cortical thinning and altered functional brain coherence in survivors of childhood sarcoma

  2020cites this paper
• Strategies for Improved Intra-arterial Treatments Targeting Brain Tumors: a Systematic Review

  2020cites this paper
• Diagnostic and prognostic biomarkers for HAND

  2019cites this paper
• Selective monoaminergic and histaminergic circuit dysregulation following long-term HIV-1 protein exposure

  2019cites this paper
• Central Nervous System Vasculitis and Related Diseases

  2019cites this paper
• Combined HIV-1 Tat and oxycodone activate the hypothalamic-pituitary-adrenal and -gonadal axes and promote psychomotor, affective, and cognitive dysfunction in female mice.

  2019cites this paper
• Posterior Reversible Encephalopathy Syndrome after a Variety of Combined Chemotherapies Containing Bevacizumab for Metastatic Colon Cancer

  2018cites this paper
• Chemotherapy and the pediatric brain

  2018cites this paper
• Posterior Reversible Encephalopathy Syndrome Associated with Bevacizumab

  2018cites this paper
• Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature

  2016cites this paper
• Reversible posterior leukoencephalopathy syndrome following combinatorial cisplatin and pemetrexed therapy for lung cancer in a normotensive patient: A case report and literature review.

  2016cites this paper
• Chemotherapy-induced neurotoxicity in pediatric solid non-CNS tumor patients: An update on current state of research and recommended future directions.

  2016cites this paper
• Evaluation of drug-induced neurotoxicity based on metabolomics, proteomics and electrical activity measurements in complementary CNS in vitro models.

  2015cites this paper
• Cerebellum neurotransmission during postnatal development: [Pt(O,O′‐acac)(γ‐acac)(DMS)] vs cisplatin and neurotoxicity

  2015cites this paper
• 3 Evaluation of drug-induced neurotoxicity based on metabolomics, 4 proteomics and electrical activity measurements in complementary CNS

  2015cites this paper
• In vitro blood-brain barrier model adapted to repeated-dose toxicological screening.

  2013cites this paper
• Platinum drugs and neurotoxicity: effects on intracellular calcium homeostasis

  2013cites this paper
• Utilisation de modèles in vitro de la barrière hémato-encéphalique dans les phases précoces du développement de médicaments

  2013cites this paper
• The developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum.

  2011cites this paper
• Developing Central Nervous System and Vulnerability to Platinum Compounds

  2011cites this paper
• Gemcitabine and cisplatin chemotherapy induced reversible posterior leukoencephalopathy syndrome in a bladder cancer patient

  2010cites this paper
• CNS complications of radiotherapy and chemotherapy.

  2009cites this paper
• CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo

  2006cites this paper
• Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia

  2005cites this paper